| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |